Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis

Ann Rheum Dis. 2019 Mar;78(3):e21. doi: 10.1136/annrheumdis-2018-213157. Epub 2018 Feb 16.

Authors

Hui-Zi Li¹, Xiang-He Xu¹, Nan Lin¹, Hua-Ding Lu¹

Affiliation

¹ Department of Orthopaedics, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.

PMID: 29453218
DOI: 10.1136/annrheumdis-2018-213157

No abstract available

Keywords: cardiovascular disease; osteoarthritis; rheumatoid arthritis.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antirheumatic Agents*
Arthritis, Rheumatoid*
Humans
Hydroxychloroquine

Substances

Antirheumatic Agents
Hydroxychloroquine